Rheumatoid Arthritis - Pipeline Review, H1 2018

Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2018’, provides an overview of the Rheumatoid Arthritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rheumatoid Arthritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Rheumatoid Arthritis and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the global therapeutic landscape of Rheumatoid Arthritis

The report reviews pipeline therapeutics for Rheumatoid Arthritis by companies and universities/research institutes based on information derived from company and industry-specific sources

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved Rheumatoid Arthritis therapeutics and enlists all their major and minor projects

The report assesses Rheumatoid Arthritis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news related to pipeline therapeutics for Rheumatoid Arthritis

Reasons to buy

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Rheumatoid Arthritis

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Rheumatoid Arthritis pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

3SBio Inc

4D Pharma PLC

AB Science SA

AbbVie Inc

Ablynx NV

ACEA Biosciences Inc

Aclaris Therapeutics Inc

Adello Biologics LLC

Alteogen Inc

Amarna Therapeutics ...

3SBio Inc

4D Pharma PLC

AB Science SA

AbbVie Inc

Ablynx NV

ACEA Biosciences Inc

Aclaris Therapeutics Inc

Adello Biologics LLC

Alteogen Inc

Amarna Therapeutics BV

Amgen Inc

Applied Genetic Technologies Corp

Aptevo Therapeutics Inc

arGentis Pharmaceuticals LLC

Arrien Pharmaceuticals LLC

Arthrogen BV

Asahi Kasei Pharma Corp

Astellas Pharma Inc

AstraZeneca Plc

Atlantic Bio Sci LLC

Aurigene Discovery Technologies Ltd

Axsome Therapeutics Inc

Axxam SpA

Baliopharm AG

Bayer AG

Beijing Hanmi Pharmaceutical Co Ltd

Bio-Cancer Treatment International Ltd

Biocad

Biocon Ltd

Biogen Inc

BioLingus AG

BioLite Inc

Biozeus Pharmaceutical SA

Bird Rock Bio Inc

Boehringer Ingelheim GmbH

Bristol-Myers Squibb Co

BTB Pharma AB

Can-Fite BioPharma Ltd

Cardax Inc

Carna Biosciences Inc

CASI Pharmaceuticals Inc

CEL-SCI Corp

Celgene Corp

Celltrion Inc

Chipscreen Biosciences Ltd

ChironWells GmbH

Chong Kun Dang Pharmaceutical Corp

CJ HealthCare Corp

Clevexel Pharma SAS

Coherus BioSciences Inc

Commence Bio Inc

Compugen Ltd

Crossject SA

CSL Ltd

Cyclacel Pharmaceuticals Inc

Cyxone AB

Daewoong Pharmaceutical Co Ltd

Diamyd Medical AB

Diurnal Group Plc

Domainex Ltd

Dr. Reddy's Laboratories Ltd

Ducentis BioTherapeutics Ltd

Eisai Co Ltd

Enceladus Pharmaceuticals BV

Enzene Biosciences Ltd

F. Hoffmann-La Roche Ltd

Fountain Biopharma Inc

Fresenius SE & Co KGaA

Fujifilm Holdings Corporation

Galapagos NV

Gene Techno Science Co Ltd

Genentech Inc

Genfit SA

Genor BioPharma Co Ltd

Genosco Inc

Gilead Sciences Inc

GlaxoSmithKline Plc

Guangdong Zhongsheng Pharmaceutical Co Ltd

Han Wha Pharma Co Ltd

Hanmi Pharmaceuticals Co Ltd

Hansa Medical AB

Hanwha Chemical Corp

HitGen LTD

Huabo Biopharm Co Ltd

Hualan Biological Engineering Inc

Hutchison MediPharma Ltd

ID Pharma Co Ltd

Idogen AB

Immune Response BioPharma Inc

Immungenetics AG

ImmunoFrontier Inc

ImmunoPrecise Antibodies Ltd

Immunwork Inc

Innate Pharma SA

Innovent Biologics Inc

Intas Pharmaceuticals Ltd

Istesso Ltd

Japan Tobacco Inc

JHL Biotech Inc

Jiangsu Hengrui Medicine Co Ltd

Johnson & Johnson

Jyant Technologies Inc

Kadmon Corp LLC

KAHR medical Ltd

Kang Stem Biotech Co Ltd

KBP BioSciences Co Ltd

Kezar Life Sciences Inc

Lead Pharma Holding BV

LG Chem Ltd

Lipocure Ltd

Livzon Pharmaceutical Group Inc

LSK BioPartners Inc

Lupin Ltd

Mabion SA

mAbxience SA

Maruho Co Ltd

Mebiopharm Co Ltd

MedAnnex Ltd

MedImmune LLC

Merck & Co Inc

Merck KGaA

Mesoblast Ltd

Millennium Pharmaceuticals Inc

Mitsubishi Tanabe Pharma Corp

Momenta Pharmaceuticals Inc

Morphotek Inc

Mycenax Biotech Inc

MYOS RENS Technology Inc

Navigen Inc

Nichi-Iko Pharmaceutical Co Ltd

Nissan Chemical Industries Ltd

Nordic Group BV

Novartis AG

NovelMed Therapeutics Inc

NovImmune SA

Nuevolution AB

Numab Innovation AG

Omeros Corp

Oncodesign SA

OncoImmune Inc

Ono Pharmaceutical Co Ltd

OSE Immunotherapeutics

Paras Biopharmaceuticals Finland Oy

Peptinov SAS

Pfizer Inc

Pharmedartis GmbH

Philogen SpA

PlantForm Corp

PLx Pharma Inc

Principia Biopharma Inc

ProNoxis AB

Protab Ltd

Protalex Inc

Protheragen Inc

Qilu Pharmaceutical Co Ltd

Qu Biologics Inc

R Pharm

ReceptoPharm Inc

RedHill Biopharma Ltd

Reliance Life Sciences Pvt Ltd

Resverlogix Corp

ReveraGen BioPharma Inc

Rhizen Pharmaceuticals SA

Ribomic Inc

Richter Gedeon Nyrt

Rottapharm Biotech Srl

Saje Pharma LLC

Sandoz International GmbH

Sareum Holdings Plc

SBI Biotech Co Ltd

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

Shanghai Henlius Biotech Co Ltd

Shanghai Pharmaceutical Co Ltd

Simcere Pharmaceutical Group

Synermore Biologics Co Ltd

Taiho Pharmaceutical Co Ltd

Takeda Pharmaceutical Co Ltd

Teijin Pharma Ltd

TheraMAB LLC

Tiziana Life Sciences Plc

Toleranzia AB

TTY Biopharm Company Ltd

Tumorend LLC

Twoxar Inc

TxCell SA

UCB SA

United BioPharma Inc

Vaccinex Inc

Valeant Pharmaceuticals International Inc

Vicore Pharma AB

X-Rx Inc

Xbrane Biopharma AB

XL-protein GmbH

YiChang Humanwell Pharmaceutical Co Ltd

Yungjin Pharm Co Ltd

Yuyu Pharma Inc

Zhejiang Hisun Pharmaceutical Co Ltd

Table of Contents

Table of Contents

Table of Contents 2

Introduction 10

Rheumatoid Arthritis – Overview 11

Rheumatoid Arthritis – Therapeutics Development 12

Rheumatoid Arthritis – Therapeutics Assessment ...

Table of Contents

Table of Contents 2

Introduction 10

Rheumatoid Arthritis – Overview 11

Rheumatoid Arthritis – Therapeutics Development 12

Rheumatoid Arthritis – Therapeutics Assessment 60

Rheumatoid Arthritis – Companies Involved in Therapeutics Development 80

Rheumatoid Arthritis – Drug Profiles 167

Rheumatoid Arthritis – Dormant Projects 915

Rheumatoid Arthritis – Discontinued Products 950

Rheumatoid Arthritis – Product Development Milestones 957

Appendix 971

List of Tables

List of Tables

Number of Products under Development for Rheumatoid Arthritis, H1 2018

Number of Products under Development by Companies, H1 2018

Number of Products ...

List of Tables

Number of Products under Development for Rheumatoid Arthritis, H1 2018

Number of Products under Development by Companies, H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..1), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..2), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..3), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..4), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..5), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..6), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..7), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..8), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..9), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..10), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..11), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..12), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..13), H1 2018

Number of Products under Development by Universities/Institutes, H1 2018

Number of Products under Development by Universities/Institutes, H1 2018 (Contd..1), H1 2018

Products under Development by Companies, H1 2018

Products under Development by Companies, H1 2018 (Contd..1), H1 2018

Products under Development by Companies, H1 2018 (Contd..2), H1 2018

Products under Development by Companies, H1 2018 (Contd..3), H1 2018

Products under Development by Companies, H1 2018 (Contd..4), H1 2018

Products under Development by Companies, H1 2018 (Contd..5), H1 2018

Products under Development by Companies, H1 2018 (Contd..6), H1 2018

Products under Development by Companies, H1 2018 (Contd..7), H1 2018

Products under Development by Companies, H1 2018 (Contd..8), H1 2018

Products under Development by Companies, H1 2018 (Contd..9), H1 2018

Products under Development by Companies, H1 2018 (Contd..10), H1 2018

Products under Development by Companies, H1 2018 (Contd..11), H1 2018

Products under Development by Companies, H1 2018 (Contd..12), H1 2018

Products under Development by Companies, H1 2018 (Contd..13), H1 2018

Products under Development by Companies, H1 2018 (Contd..14), H1 2018

Products under Development by Companies, H1 2018 (Contd..15), H1 2018

Products under Development by Companies, H1 2018 (Contd..16), H1 2018

Products under Development by Companies, H1 2018 (Contd..17), H1 2018

Products under Development by Companies, H1 2018 (Contd..18), H1 2018

Products under Development by Companies, H1 2018 (Contd..19), H1 2018

Products under Development by Companies, H1 2018 (Contd..20), H1 2018

Products under Development by Companies, H1 2018 (Contd..21), H1 2018

Products under Development by Companies, H1 2018 (Contd..22), H1 2018

Products under Development by Companies, H1 2018 (Contd..23), H1 2018

Products under Development by Universities/Institutes, H1 2018

Products under Development by Universities/Institutes, H1 2018 (Contd..1), H1 2018

Number of Products by Stage and Target, H1 2018

Number of Products by Stage and Target, H1 2018 (Contd..1), H1 2018

Number of Products by Stage and Target, H1 2018 (Contd..2), H1 2018

Number of Products by Stage and Target, H1 2018 (Contd..3), H1 2018

Number of Products by Stage and Target, H1 2018 (Contd..4), H1 2018

Number of Products by Stage and Target, H1 2018 (Contd..5), H1 2018

Number of Products by Stage and Target, H1 2018 (Contd..6), H1 2018

Number of Products by Stage and Mechanism of Action, H1 2018

Number of Products by Stage and Mechanism of Action, H1 2018 (Contd..1), H1 2018

Number of Products by Stage and Mechanism of Action, H1 2018 (Contd..2), H1 2018

Number of Products by Stage and Mechanism of Action, H1 2018 (Contd..3), H1 2018

Number of Products by Stage and Mechanism of Action, H1 2018 (Contd..4), H1 2018

Number of Products by Stage and Mechanism of Action, H1 2018 (Contd..5), H1 2018

Number of Products by Stage and Mechanism of Action, H1 2018 (Contd..6), H1 2018

Number of Products by Stage and Route of Administration, H1 2018

Number of Products by Stage and Molecule Type, H1 2018

Rheumatoid Arthritis – Pipeline by 3SBio Inc, H1 2018

Rheumatoid Arthritis – Pipeline by 4D Pharma PLC, H1 2018

Rheumatoid Arthritis – Pipeline by AB Science SA, H1 2018

Rheumatoid Arthritis – Pipeline by AbbVie Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Ablynx NV, H1 2018

Rheumatoid Arthritis – Pipeline by ACEA Biosciences Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Aclaris Therapeutics Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Adello Biologics LLC, H1 2018

Rheumatoid Arthritis – Pipeline by Alteogen Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Amarna Therapeutics BV, H1 2018

Rheumatoid Arthritis – Pipeline by Amgen Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Applied Genetic Technologies Corp, H1 2018

Rheumatoid Arthritis – Pipeline by Aptevo Therapeutics Inc, H1 2018

Rheumatoid Arthritis – Pipeline by arGentis Pharmaceuticals LLC, H1 2018

Rheumatoid Arthritis – Pipeline by Arrien Pharmaceuticals LLC, H1 2018

Rheumatoid Arthritis – Pipeline by Arthrogen BV, H1 2018

Rheumatoid Arthritis – Pipeline by Asahi Kasei Pharma Corp, H1 2018

Rheumatoid Arthritis – Pipeline by Astellas Pharma Inc, H1 2018

Rheumatoid Arthritis – Pipeline by AstraZeneca Plc, H1 2018

Rheumatoid Arthritis – Pipeline by Atlantic Bio Sci LLC, H1 2018

Rheumatoid Arthritis – Pipeline by Aurigene Discovery Technologies Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Axsome Therapeutics Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Axxam SpA, H1 2018

Rheumatoid Arthritis – Pipeline by Baliopharm AG, H1 2018

Rheumatoid Arthritis – Pipeline by Bayer AG, H1 2018

Rheumatoid Arthritis – Pipeline by Beijing Hanmi Pharmaceutical Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Bio-Cancer Treatment International Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Biocad, H1 2018

Rheumatoid Arthritis – Pipeline by Biocon Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Biogen Inc, H1 2018

Rheumatoid Arthritis – Pipeline by BioLingus AG, H1 2018

Rheumatoid Arthritis – Pipeline by BioLite Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Biozeus Pharmaceutical SA, H1 2018

Rheumatoid Arthritis – Pipeline by Bird Rock Bio Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Boehringer Ingelheim GmbH, H1 2018

Rheumatoid Arthritis – Pipeline by Bristol-Myers Squibb Co, H1 2018

Rheumatoid Arthritis – Pipeline by BTB Pharma AB, H1 2018

Rheumatoid Arthritis – Pipeline by Can-Fite BioPharma Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Cardax Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Carna Biosciences Inc, H1 2018

Rheumatoid Arthritis – Pipeline by CASI Pharmaceuticals Inc, H1 2018

Rheumatoid Arthritis – Pipeline by CEL-SCI Corp, H1 2018

Rheumatoid Arthritis – Pipeline by Celgene Corp, H1 2018

Rheumatoid Arthritis – Pipeline by Celltrion Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Chipscreen Biosciences Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by ChironWells GmbH, H1 2018

Rheumatoid Arthritis – Pipeline by Chong Kun Dang Pharmaceutical Corp, H1 2018

Rheumatoid Arthritis – Pipeline by CJ HealthCare Corp, H1 2018

Rheumatoid Arthritis – Pipeline by Clevexel Pharma SAS, H1 2018

Rheumatoid Arthritis – Pipeline by Coherus BioSciences Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Commence Bio Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Compugen Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Crossject SA, H1 2018

Rheumatoid Arthritis – Pipeline by CSL Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Cyclacel Pharmaceuticals Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Cyxone AB, H1 2018

Rheumatoid Arthritis – Pipeline by Daewoong Pharmaceutical Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Diamyd Medical AB, H1 2018

Rheumatoid Arthritis – Pipeline by Diurnal Group Plc, H1 2018

Rheumatoid Arthritis – Pipeline by Domainex Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Dr. Reddy's Laboratories Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Ducentis BioTherapeutics Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Eisai Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Enceladus Pharmaceuticals BV, H1 2018

Rheumatoid Arthritis – Pipeline by Enzene Biosciences Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by F. Hoffmann-La Roche Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Fountain Biopharma Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Fresenius SE & Co KGaA, H1 2018

Rheumatoid Arthritis – Pipeline by Fujifilm Holdings Corporation, H1 2018

Rheumatoid Arthritis – Pipeline by Galapagos NV, H1 2018

Rheumatoid Arthritis – Pipeline by Gene Techno Science Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Genentech Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Genfit SA, H1 2018

Rheumatoid Arthritis – Pipeline by Genor BioPharma Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Genosco Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Gilead Sciences Inc, H1 2018

Rheumatoid Arthritis – Pipeline by GlaxoSmithKline Plc, H1 2018

Rheumatoid Arthritis – Pipeline by Guangdong Zhongsheng Pharmaceutical Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Han Wha Pharma Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Hanmi Pharmaceuticals Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Hansa Medical AB, H1 2018

Rheumatoid Arthritis – Pipeline by Hanwha Chemical Corp, H1 2018

Rheumatoid Arthritis – Pipeline by HitGen LTD, H1 2018

Rheumatoid Arthritis – Pipeline by Huabo Biopharm Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Hualan Biological Engineering Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Hutchison MediPharma Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by ID Pharma Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Idogen AB, H1 2018

Rheumatoid Arthritis – Pipeline by Immune Response BioPharma Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Immungenetics AG, H1 2018

Rheumatoid Arthritis – Pipeline by ImmunoFrontier Inc, H1 2018

Rheumatoid Arthritis – Pipeline by ImmunoPrecise Antibodies Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Immunwork Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Innate Pharma SA, H1 2018

Rheumatoid Arthritis – Pipeline by Innovent Biologics Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Intas Pharmaceuticals Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Istesso Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Japan Tobacco Inc, H1 2018

Rheumatoid Arthritis – Pipeline by JHL Biotech Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Jiangsu Hengrui Medicine Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Johnson & Johnson, H1 2018

Rheumatoid Arthritis – Pipeline by Jyant Technologies Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Kadmon Corp LLC, H1 2018

Rheumatoid Arthritis – Pipeline by KAHR medical Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Kang Stem Biotech Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by KBP BioSciences Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Kezar Life Sciences Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Lead Pharma Holding BV, H1 2018

Rheumatoid Arthritis – Pipeline by LG Chem Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Lipocure Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Livzon Pharmaceutical Group Inc, H1 2018

Rheumatoid Arthritis – Pipeline by LSK BioPartners Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Lupin Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Mabion SA, H1 2018

Rheumatoid Arthritis – Pipeline by mAbxience SA, H1 2018

Rheumatoid Arthritis – Pipeline by Maruho Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Mebiopharm Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by MedAnnex Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by MedImmune LLC, H1 2018

Rheumatoid Arthritis – Pipeline by Merck & Co Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Merck KGaA, H1 2018

Rheumatoid Arthritis – Pipeline by Mesoblast Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Millennium Pharmaceuticals Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Mitsubishi Tanabe Pharma Corp, H1 2018

Rheumatoid Arthritis – Pipeline by Momenta Pharmaceuticals Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Morphotek Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Mycenax Biotech Inc, H1 2018

Rheumatoid Arthritis – Pipeline by MYOS RENS Technology Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Navigen Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Nichi-Iko Pharmaceutical Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Nissan Chemical Industries Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Nordic Group BV, H1 2018

Rheumatoid Arthritis – Pipeline by Novartis AG, H1 2018

Rheumatoid Arthritis – Pipeline by NovelMed Therapeutics Inc, H1 2018

Rheumatoid Arthritis – Pipeline by NovImmune SA, H1 2018

Rheumatoid Arthritis – Pipeline by Nuevolution AB, H1 2018

Rheumatoid Arthritis – Pipeline by Numab Innovation AG, H1 2018

Rheumatoid Arthritis – Pipeline by Omeros Corp, H1 2018

Rheumatoid Arthritis – Pipeline by Oncodesign SA, H1 2018

Rheumatoid Arthritis – Pipeline by OncoImmune Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Ono Pharmaceutical Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by OSE Immunotherapeutics, H1 2018

Rheumatoid Arthritis – Pipeline by Paras Biopharmaceuticals Finland Oy, H1 2018

Rheumatoid Arthritis – Pipeline by Peptinov SAS, H1 2018

Rheumatoid Arthritis – Pipeline by Pfizer Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Pharmedartis GmbH, H1 2018

Rheumatoid Arthritis – Pipeline by Philogen SpA, H1 2018

Rheumatoid Arthritis – Pipeline by PlantForm Corp, H1 2018

Rheumatoid Arthritis – Pipeline by PLx Pharma Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Principia Biopharma Inc, H1 2018

Rheumatoid Arthritis – Pipeline by ProNoxis AB, H1 2018

Rheumatoid Arthritis – Pipeline by Protab Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Protalex Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Protheragen Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Qilu Pharmaceutical Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Qu Biologics Inc, H1 2018

Rheumatoid Arthritis – Pipeline by R Pharm, H1 2018

Rheumatoid Arthritis – Pipeline by ReceptoPharm Inc, H1 2018

Rheumatoid Arthritis – Pipeline by RedHill Biopharma Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Reliance Life Sciences Pvt Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Resverlogix Corp, H1 2018

Rheumatoid Arthritis – Pipeline by ReveraGen BioPharma Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Rhizen Pharmaceuticals SA, H1 2018

Rheumatoid Arthritis – Pipeline by Ribomic Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Richter Gedeon Nyrt, H1 2018

Rheumatoid Arthritis – Pipeline by Rottapharm Biotech Srl, H1 2018

Rheumatoid Arthritis – Pipeline by Saje Pharma LLC, H1 2018

Rheumatoid Arthritis – Pipeline by Sandoz International GmbH, H1 2018

Rheumatoid Arthritis – Pipeline by Sareum Holdings Plc, H1 2018

Rheumatoid Arthritis – Pipeline by SBI Biotech Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Shanghai Henlius Biotech Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Shanghai Pharmaceutical Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Simcere Pharmaceutical Group, H1 2018

Rheumatoid Arthritis – Pipeline by Synermore Biologics Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Taiho Pharmaceutical Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Takeda Pharmaceutical Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Teijin Pharma Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by TheraMAB LLC, H1 2018

Rheumatoid Arthritis – Pipeline by Tiziana Life Sciences Plc, H1 2018

Rheumatoid Arthritis – Pipeline by Toleranzia AB, H1 2018

Rheumatoid Arthritis – Pipeline by TTY Biopharm Company Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Tumorend LLC, H1 2018

Rheumatoid Arthritis – Pipeline by Twoxar Inc, H1 2018

Rheumatoid Arthritis – Pipeline by TxCell SA, H1 2018

Rheumatoid Arthritis – Pipeline by UCB SA, H1 2018

Rheumatoid Arthritis – Pipeline by United BioPharma Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Vaccinex Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Valeant Pharmaceuticals International Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Vicore Pharma AB, H1 2018

Rheumatoid Arthritis – Pipeline by X-Rx Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Xbrane Biopharma AB, H1 2018

Rheumatoid Arthritis – Pipeline by XL-protein GmbH, H1 2018

Rheumatoid Arthritis – Pipeline by YiChang Humanwell Pharmaceutical Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Yungjin Pharm Co Ltd, H1 2018

Rheumatoid Arthritis – Pipeline by Yuyu Pharma Inc, H1 2018

Rheumatoid Arthritis – Pipeline by Zhejiang Hisun Pharmaceutical Co Ltd, H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..1), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..2), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..3), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..4), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..5), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..6), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..7), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..8), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..9), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..10), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..11), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..12), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..13), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..14), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..15), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..16), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..17), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..18), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..19), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..20), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..21), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..22), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..23), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..24), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..25), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..26), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..27), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..28), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..29), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..30), H1 2018

Rheumatoid Arthritis – Dormant Projects, H1 2018 (Contd..31), H1 2018

Rheumatoid Arthritis – Discontinued Products, H1 2018

Rheumatoid Arthritis – Discontinued Products, H1 2018 (Contd..1), H1 2018

Rheumatoid Arthritis – Discontinued Products, H1 2018 (Contd..2), H1 2018

Rheumatoid Arthritis – Discontinued Products, H1 2018 (Contd..3), H1 2018

Rheumatoid Arthritis – Discontinued Products, H1 2018 (Contd..4), H1 2018

Rheumatoid Arthritis – Discontinued Products, H1 2018 (Contd..5), H1 2018

Rheumatoid Arthritis – Discontinued Products, H1 2018 (Contd..6), H1 2018

List of Figures

List of Figures

Number of Products under Development for Rheumatoid Arthritis, H1 2018

Number of Products under Development by Companies, H1 2018

Number of Products ...

List of Figures

Number of Products under Development for Rheumatoid Arthritis, H1 2018

Number of Products under Development by Companies, H1 2018

Number of Products under Development by Universities/Institutes, H1 2018

Number of Products by Top 10 Targets, H1 2018

Number of Products by Stage and Top 10 Targets, H1 2018

Number of Products by Top 10 Mechanism of Actions, H1 2018

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018

Number of Products by Top 10 Routes of Administration, H1 2018

Number of Products by Stage and Top 10 Routes of Administration, H1 2018

Number of Products by Top 10 Molecule Types, H1 2018

Number of Products by Stage and Top 10 Molecule Types, H1 2018

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports